Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer

Acta Oncol. 2018 May;57(5):681-682. doi: 10.1080/0284186X.2017.1374556. Epub 2017 Nov 15.

Authors

Cornelis J A Punt¹, Joost Huiskens¹, Thomas van Gulik², Marc Engelbrecht³

Affiliations

¹ a Department of Medical Oncology , Academic Medical Center, University of Amsterdam, Amsterdam , The Netherlands.
² b Department of Surgery , Academic Medical Center, University of Amsterdam, Amsterdam , The Netherlands.
³ c Department of Radiology , Academic Medical Center, University of Amsterdam, Amsterdam , The Netherlands.

PMID: 29140135
DOI: 10.1080/0284186X.2017.1374556

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab / therapeutic use*
Colorectal Neoplasms / drug therapy*
Colorectal Neoplasms / pathology
Disease Progression
Humans
Male
Middle Aged
Neoplasm Metastasis
Remission Induction / methods
Treatment Outcome
Tumor Burden / drug effects*
Withholding Treatment

Substances

Bevacizumab